CCI approves acquisition of Kenvue Inc. by Kimberly-Clark (See 'Corp Brief') CCI approves Adani Power to buy stake of GVK Energy (See 'Corp Brief') IBC - If transaction was builder-linked contractual arrangement rather than pure financial debt default, Section 7 IBC proceedings cannot be used in parallel with DRT recovery proceedings: SC (See 'Legal Desk') CCI approves acquisition of stake in Llyods Engineering by Thriveni Earthmovers (See 'Corp Brief') CCI approves acquisition by CPPIB India in Ctrl S Datacenters (See 'Corp Brief') Govt pushes India Post toward Corporate-Style Efficiency (See 'Corp Brief') IPR - Use of house mark does not by itself obviate infringement or passing off: HC (See 'Legal Desk') Present petro conservation intended towards long-run capacity building: RM (See 'Corp Brief') Atal Innovation Mission hosts AIM Sumvaad- Central India to strengthen regional incubators (See 'Corp Brief') FERA - Foreign judgment is unenforceable in India as it fell within exceptions u/s 13 CPC: SC (See 'Legal Desk') Forum of Regulators celebrates 21 Years of strengthening India's Power Sector (See 'Corp Brief') A&C - Once seat of arbitration is expressly designated by agreement of parties, that seat becomes juridical home of arbitration and operates akin to exclusive jurisdiction clause: SC (See 'Legal Desk') Supreme Court lays down scenarios for lifting of Doctrine of Corporate Veil (See 'CORP EINSICHTf') Fisheries Secy visits ornamental fish brood bank in Maharashtra (See 'Corp Brief') Company Law - For purpose of maintainability of petitions u/s 397 & 398, expression ‘member' is not to be confined only to formal entry in register of members u/s 41(2): SC (See 'Legal Desk') Over 3,500 Participants compete in AB PM-JAY Hackathon (See 'Corp Brief') Scindia, Fadnavis inaugurate renovated Andheri RS Post Office as Future-Ready Service Hub (See 'Corp Brief') IBC - While subsidiary companies are separate legal entities, corporate veil may be lifted if associated companies are inextricably connected so as to form one concern: SC (See 'Legal Desk')

Print

Sun Pharma subsidiary to acquire 12.5 per cent stake in Australia-based WRS Bioproducts

Published: Mar 06, 2021

By TIOLCORPLAWS News Service

MUMBAI, MAR 06, 2021: DRUG major Sun Pharmaceuticals said on Friday that its wholly-owned subsidiary will acquire 428,571 ordinary shares, equivalent to 12.5 per cent stake, in Australia-based nutraceutical and food supplements company, WRS Bioproducts.

WRS Bioproducts is an early-stage company that grows diverse algae, harvest, extract and purify high-value ingredients for sale to dietary supplements, food, cosmetic and animal nutrition markets using their own novel technologies.

Sun Pharma will pay AUD 2 million Australian dollars for the 12.5 per cent stake, on a fully diluted basis, and expects to complete the acquisition by March 15.

Sun Pharma is an Indian multinational pharmaceutical company which is the world's fourth largest specialty generic drug manufacturer.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
tioltube
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.